Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Intrinsic Value
Torrent Pharmaceuticals Ltd. engages in the research, development, manufacture, and marketing of generic pharmaceutical formulations. [ Read More ]
The intrinsic value of one TORNTPHARM stock under the Base Case scenario is 1 655.31 INR. Compared to the current market price of 2 654.55 INR, Torrent Pharmaceuticals Ltd is Overvalued by 38%.
Valuation Backtest
Torrent Pharmaceuticals Ltd
Run backtest to discover the historical profit from buying and selling TORNTPHARM stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Torrent Pharmaceuticals Ltd
| Current Assets | 52.9B |
| Cash & Short-Term Investments | 9.4B |
| Receivables | 17.6B |
| Other Current Assets | 25.9B |
| Non-Current Assets | 94.6B |
| Long-Term Investments | 980m |
| PP&E | 34.6B |
| Intangibles | 51.8B |
| Other Non-Current Assets | 7.3B |
| Current Liabilities | 49B |
| Accounts Payable | 16.6B |
| Other Current Liabilities | 32.4B |
| Non-Current Liabilities | 31.4B |
| Long-Term Debt | 21.6B |
| Other Non-Current Liabilities | 9.8B |
Earnings Waterfall
Torrent Pharmaceuticals Ltd
|
Revenue
|
104.7B
INR
|
|
Cost of Revenue
|
-27.1B
INR
|
|
Gross Profit
|
77.6B
INR
|
|
Operating Expenses
|
-53.5B
INR
|
|
Operating Income
|
24.1B
INR
|
|
Other Expenses
|
-9.1B
INR
|
|
Net Income
|
15B
INR
|
Free Cash Flow Analysis
Torrent Pharmaceuticals Ltd
TORNTPHARM Profitability Score
Profitability Due Diligence
Torrent Pharmaceuticals Ltd's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
Score
Torrent Pharmaceuticals Ltd's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
TORNTPHARM Solvency Score
Solvency Due Diligence
Torrent Pharmaceuticals Ltd's solvency score is 60/100. The higher the solvency score, the more solvent the company is.
Score
Torrent Pharmaceuticals Ltd's solvency score is 60/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
TORNTPHARM Price Targets Summary
Torrent Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for TORNTPHARM is 2 671.07 INR with a low forecast of 1 935.16 INR and a high forecast of 3 123.75 INR.
Shareholder Return
TORNTPHARM Price
Torrent Pharmaceuticals Ltd
| Average Annual Return | 20.08% |
| Standard Deviation of Annual Returns | 23.65% |
| Max Drawdown | -11% |
| Market Capitalization | 898.4B INR |
| Shares Outstanding | 338 445 440 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Torrent Pharmaceuticals Ltd. engages in the research, development, manufacture, and marketing of generic pharmaceutical formulations. The company is headquartered in Ahmedabad, Gujarat and currently employs 12,910 full-time employees. The firm is engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations. The company operates in the therapeutic segments of cardiovascular (CV), gastrointestinal (GI), central nervous system (CNS), and vitamins minerals nutritionals (VMN). The company also has presence in therapeutic areas, such as anti-epileptic, anti-diabetic, anti-cancer, anti-acne, corticosteroids and cosmeceuticals. The company has developed complex formulations for global markets based on oral solids, injections, inhalation technologies, long-acting depot injections ophthalmic, nasal, semisolids for external applications and multi-particulate extended-release oral systems. The firm is developing various in-house new chemical entities (NCE) in the areas of metabolic, cardiovascular, gastrointestinal, dermatological and respiratory disorders. The company has a presence across more than 40 countries.
Contact
IPO
Employees
Officers
The intrinsic value of one TORNTPHARM stock under the Base Case scenario is 1 655.31 INR.
Compared to the current market price of 2 654.55 INR, Torrent Pharmaceuticals Ltd is Overvalued by 38%.
You don't have any saved screeners yet
